As Partner, Mr. Poole has extensive investment and transaction experience. He is responsible for transaction origination and execution, portfolio company value creation initiatives, investment policy, and investor relations. He is also a member of the Private Equity investment committee and currently serves on the Board of Directors of Azurity Pharmaceuticals and CoreRx, two NovaQuest Private Equity portfolio companies.
Prior to joining NovaQuest, Mr. Poole was Chairman and Chief Executive Officer of Triangle Capital Corporation, a publicly traded business development company making private debt and equity investments in lower middle market companies across a variety of industries, including healthcare. In that role, he was responsible for setting corporate strategy and managing key functional areas of the company, including investment origination, underwriting, portfolio monitoring, capital raising, and investor relations. Mr. Poole served on the Management Committee, Investment Committee and Board of Directors of the company.
Mr. Poole’s previous experience also includes 19 years of corporate finance and M&A advisory work for Morgan Stanley, where he was a Managing Director in the investment banking division and worked out of the New York office. Mr. Poole started his career in strategy consulting, where he worked for 3 years in San Francisco at The MAC Group, which was subsequently acquired by Gemini Consulting.